SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX) -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (325)4/27/2004 2:02:29 PM
From: Icebrg  Read Replies (1) | Respond to of 590
 
Abgenix "buy," target price raised

Tuesday, April 27, 2004 12:37:01 PM ET
Merrill Lynch

NEW YORK, April 27 (New Ratings) - Analysts at Merrill Lynch reiterate their "buy" rating on Abgenix (ABGX.NAS). The target price has been raised from $17 to $24.